A Single Dose Bioequivalence Study Comparing the Commercial Tablet Formulation to the Clinical Tablet of Bosutinib in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2010
At a glance
- Drugs Bosutinib (Primary)
- Indications Breast cancer; Myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma; Solid tumours
- Focus Pharmacokinetics
- Sponsors Wyeth
- 30 Jul 2010 Actual initiation date added to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 30 Jul 2010 Actual end date added to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 30 Jul 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.`